journal article·2017-07

A versatile fluorescent molecular probe endowed with singlet oxygen generation under white-light photosensitization

G. Durán-Sampedro, N. Epelde-Elezcano, V. Martínez-Martínez, I. Esnal, J. Bañuelos, I. García-Moreno, A.R. Agarrabeitia, S. de la Moya, A. Tabero, A. Lazaro-Carrillo, A. Villanueva, M.J. Ortiz, I. López-Arbeloa

Dyes and Pigments· Volume 142
Publisher page

Abstract

Despite fluorescent photodynamic therapy (fluorescent-PDT) dyes are promising theranostic agents, current approaches unfortunately involve crucial shortcomings (such as, narrow absorption bands, high cost, low bio-compatibility and specificity, low dual efficiency) making difficult their clinical translation. Particularly, efficient fluorescent-PDT agents triggered under white-light, with potential application in topic solar treatments, are scarce. Here, we describe the rational development of a novel fluorescent-PDT molecular biomaterial based on BODIPY building blocks able to sustain, simultaneously, synthetic accessibility, high fluorescence and phototoxicity within a broad spectral window, biocompatibility, including low dark toxicity and high cell permeability with selective accumulation in lysosomes and, what is more important, excellent efficient activity triggered under white light. These all-in-one combined properties make the new dye a valuable ground platform for the development of future smarter theranostic agents.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Theranostic nanomedicine10.1021/ar200231d ↗
2. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization10.1021/cr900300p ↗
3. Conjugation of porphyrin to nanohybrid cerasomes for photodynamic diagnosis and therapy of cancer10.1002/anie.201103557 ↗
4. Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy10.1002/adma.201200650 ↗
5. Photosensitizer-conjugated redox-responsive dextran theranostic nanoparticles for near-infrared cancer imaging and photodynamic therapy10.1039/C3PY01173A ↗
6. In vivo 808 nm image-guided photodynamic therapy based on an upconversion theranostic nanoplatform10.1039/C5NR03690A ↗
7. Triplet photosensitizers: from molecular design to applications10.1039/c3cs35531d ↗
8. Boron dipyrromethene (BODIPY)-based photosensitizers for photodynamic therapy10.1039/c2ra21404k ↗
9. BODIPY dyes in photodynamic therapy10.1039/C2CS35216H ↗
10. Oncologic photodynamic therapy: clinical strategies that modulate mechanisms of action10.1016/j.pdpdt.2013.03.011 ↗
11. Technical concepts for white light photodynamic therapy of bladder cancer10.1078/1615-1615-00044 ↗
12. Photodynamic therapy for cancer10.1038/nrc1071 ↗
13. Photodynamic therapy in dermatology
14. Current evidence and applications of photodynamic therapy in dermatology
15. Antimicrobial photodynamic therapy: an effective alternative approach to control fungal infections10.3389/fmicb.2015.00202 ↗
16. Cationic oligo(thiophene ethynylene) with broad-spectrum and high antibacterial efficiency under white light and specific biocidal activity against S. aureus in dark10.1021/acsami.5b11264 ↗
17. Targeting cancer cells by using an antireceptor antibody-photosensitizer fusion protein10.1073/pnas.0904140106 ↗
18. Image-guided combination chemotherapy and photodynamic therapy using a mitochondria-targeted molecular probe with aggregation-induced emission characteristics10.1039/C5SC00826C ↗
19. In vitro effect photodynamic therapy with differents photosensitizers on cariogenic microorganisms10.1186/s12866-015-0524-3 ↗
20. Modulation of singlet oxygen generation in halogenated BODIPY dyes by substitution at their meso position: towards a solvent-independent standard in the vis region10.1039/C6RA05820E ↗
21. Frisch · 2009
22. Measurement of co-localization of objects in dual-colour confocal images10.1111/j.1365-2818.1993.tb03313.x ↗
23. Fiji: an open-source platform for biological-image analysis10.1038/nmeth.2019 ↗
24. MTT assays allow quick and reliable measurement of the response of human tumour cells to photodynamic therapy10.1016/0959-8049(92)90542-A ↗
25. A reaction-based chromogenic and fluorescent chemodosimeter for fluoride anions10.1039/C1CC10784D ↗
26. Triplet-triplet annihilation based upconversion: from triplet sensitizers and triplet acceptors to upconversion quantum yields10.1039/c1ra00469g ↗
27. Photochemistry and photophysics of coordination compounds: platinum10.1007/128_2007_134 ↗
28. Cyclometallated platinum(ii) complexes incorporating ethynyl-flavone ligands: switching between triplet and singlet emission induced by selective binding of Pb2+ ions10.1039/b806935b ↗
29. Heavy metal organometallic electrophosphors derived from multi-component chromophores10.1016/j.ccr.2009.01.013 ↗
30. Theoretical design of phosphorescence parameters for organic electro-luminescence devices based on iridium complexes10.1016/j.chemphys.2009.02.014 ↗
31. Transition-metal phosphors with cyclometalating ligands: fundamentals and applications10.1039/B916237B ↗
32. Organic triplet sensitizer library derived from a single chromophore (BODIPY) with long-lived triplet excited state for triplet-triplet annihilation based upconversion10.1021/jo200990y ↗
33. Thienyl-substituted BODIPYs with strong visible light-absorption and long-lived triplet excited states as organic triplet sensitizers for triplet-triplet annihilation upconversion10.1039/c2ra01064j ↗
34. Transition metal complexes with strong absorption of visible light and long-lived triplet excited states: from molecular design to applications10.1039/C1RA00665G ↗
35. Designing excited states: theory-guided access to efficient photosensitizers for photodynamic action. Angew chem10.1002/anie.201105736 ↗
36. Hetero Bodipy-dimers as heavy atom-free triplet photosensitizers showing a long-lived triplet excited state for triplet-triplet annihilation upconversion10.1039/c3cc45470c ↗
37. Rapid intersystem crossing in closely-spaced but orthogonal molecular dyads10.1002/cphc.200700060 ↗
38. Effect on charge transfer and charge recombination by insertion of a naphthalene-based bridge in molecular dyads based on borondipyrromethene (bodipy)10.1002/cphc.201200510 ↗
39. Vectorial charge separation and selective triplet-state formation during charge recombination in a pyrrolyl-bridged BODIPY-fullerene dyad10.1021/acs.jpcc.5b02712 ↗
40. Intracellular modulation of excited-state dynamics in a chromophore dyad: differential enhancement of photocytotoxicity targeting cancer cells10.1002/anie.201411962 ↗
41. Characterization of the resonance energy transfer couple coumarin-bodipy and its possible applications in protein-lipid research10.1006/bbrc.1995.1217 ↗
42. Through-bond energy transfer cassettes based on coumarin-Bodipy/distyryl Bodipy dyads with efficient energy efficiencies and large pseudo-Stokes' shifts10.1039/c1jm12503f ↗
43. Nanoparticle-based theranostic agents10.1016/j.addr.2010.07.009 ↗
44. An asymmetric BODIPY triad with panchromatic absorption for high-performance red-edge laser emission10.1039/C5CC03408F ↗
45. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays10.1016/0022-1759(83)90303-4 ↗
46. Apoptosis: controlled demolition at the cellular level10.1038/nrm2312 ↗
47. Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves bid cleavage10.1038/sj.cdd.4401048 ↗
48. Promotion of proapoptotic signals by lysosomal photodamage10.1111/php.12456 ↗
49. Two combined photosensitizers: a goal for more effective photodynamic therapy of cancer10.1038/cddis.2014.77 ↗
50. Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments10.1007/s10495-005-6075-6 ↗
51. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes10.1038/cdd.2009.44 ↗